Microbio Co., Ltd.

ISIN TW0004128004

 | 

WKN A0RNR6

Market cap (in EUR)
252 m
Country
Taiwan
Sector
Consumer Non-Cyclicals
Dividend yield
0.11%
 

Overview

Description

Microbio Co., Ltd. engages in the research, development, manufacture, and sale of new drugs and healthcare products. The company also supplies raw materials to pharmaceutical companies in Taiwan. Its major products include health food, herbal products, botanical drugs, and disease prevention and nutrients supplements. The company was founded in May 3, 2000 and is headquartered in Taipei, Taiwan.
Show more Show less
Consumer Non-Cyclicals Food and Staples Retail Food and Beverage Retail Taiwan

Financials

Key metrics

Market capitalisation, EUR 252 m
EPS, EUR -0.04
P/B ratio 1.0
P/E ratio 149.5
Dividend yield 0.11%

Income statement (2025)

Revenue, EUR 54 m
Net income, EUR -22 m
Profit margin -40.01%

What ETF is Microbio Co., Ltd. in?

There are 2 ETFs which contain Microbio Co., Ltd.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Microbio Co., Ltd. is the Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing.
ETF Weight Investment focus Fund size (in m EUR)
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
507
Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing 0.00%
Equity
Emerging Markets
Social/Environmental
17
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.